Role of TLR2 and TLR4 in Stage 2 Periodontitis Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
In Health, mucosal inflammation is prevented by TLR (Toll like receptors) that interact with Specific MAMP (microbe associated molecular pattern). Currently about 13TLRs have been identified. Among them, TLR2 and 4 recognize most organisms . Periodontal disease is mixed infection resulting due to dysbiosis . When aggravated by systemic disease the role of TLRs is detrimental for the overall state of periodontal apparatus. Type 2 diabetes is one of the systemic disease which is seen a risk factor if uncontrolled can exaggerate the titer of TLR2 and TLR4 biomarkers . Various studies have been evaluated to determine the role of TLRs in autoimmune and periodontal conditions. The purpose of this study is to determine if both TLR2 and TLR4 play equal roles in periodontal disease and in cases where periodontal disease is complicated by the presence of systemic disease. Individual role of TLR2 and TLR4 in active disease will help determine treatment strategies and will also be able to predict potential biomarker in disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 15, 2019
CompletedFirst Posted
Study publicly available on registry
December 17, 2019
CompletedDecember 18, 2019
December 1, 2019
3 months
December 15, 2019
December 16, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Toll like receptor 2 activity
Toll like receptor 2 activity will be measured from saliva obtained from controls, patients with periodontal disease but no diabetes and periodontal patients with diabetes
From baseline to 5 months
Secondary Outcomes (1)
Toll like receptor 4 activity
From baseline to 5 months
Study Arms (3)
control patients
PLACEBO COMPARATOREvaluation of Toll like receptor activity from whole saliva obtained from control patients
Periodontal patients without diabetes
ACTIVE COMPARATOREvaluation of toll like receptor activity from whole saliva obtained from periodontal patients without diabetes
Periodontal patients with diabetes
ACTIVE COMPARATOREvaluation of toll like receptor activity from whole saliva obtained from periodontal patients with diabetes
Interventions
Stimulated whole saliva will be obtained from patients and tested for Toll like receptor activity
Eligibility Criteria
You may qualify if:
- \*Untreated stage 2 periodontitis patients (n-60)-Age group 21-60
- Non Smokers
- Diabetic patients controlled
- Not haven taken medications in the past 3 months
You may not qualify if:
- smoker
- habits such as betel, tobacco chewing
- systemically unstable, Diabetes uncontrolled patients
- haven taken medications in the past 3 months
- Pregnant ladies
- Periodontal involvement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ajman Universitylead
Study Sites (1)
Ajman University
Ajman, Dubai, 009714, United Arab Emirates
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 15, 2019
First Posted
December 17, 2019
Study Start
May 1, 2019
Primary Completion
August 1, 2019
Study Completion
September 1, 2019
Last Updated
December 18, 2019
Record last verified: 2019-12